Relic Pharma Limited - Company Profile

It is a financial services public limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Relic Pharma Limited

Relic Pharma Limited, a active public limited company, was established on 04 May 1995 in Mumbai, Maharashtra, India. Engaging in brokerage & trading services within the financial and insurance service sector, it holds CIN: U67120MH1995PLC088000. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.25 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Its leadership includes Hemant Kantilal Choksey (Director), Baijoo Madhusudan Raval (Director), Uday Madhusudan Raval (Director). Past directors included Hemant Kantilal Choksey, Madhusudan Mohanlal Raval, Narendra Ishwarlal Gandhi. Its latest AGM occurred on 19 August 2024, with the balance sheet filed on 31 March 2024. It is based at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, 400002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U67120MH1995PLC088000

  • Registration Number

    088000

  • Incorporation Date

    04 May 1995

  • Authorized Capital

    ₹3.25 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.25 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 31 Year, 19 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -100.00%
  • Profit Growth **** -189.29%
  • Ebitda **** 24.51%
  • Net Worth -0.11%
  • Total Assets -0.07%
Company report

Relic Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Relic Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Relic Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Hemant Kantilal Choksey Director 19 Apr 2014 Current
Baijoo Madhusudan Raval Director 04 May 1995 Current
Uday Madhusudan Raval Director 04 May 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Director 08 Apr 2014 Past
Pramod Abcsdd Director 30 May 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Relic Pharma.

Relic Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 189.29% decrease in profit. The company's net worth dipped by a decrease of 0.11%.

Relic Pharma revenue growth over time
Relic Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -100.00%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.07%
*******
*******
*******
*******
Profit or Loss
*******
 -189.29%
*******
*******
*******
*******
Net Worth
*******
 -0.11%
*******
*******
*******
*******
EBITDA
*******
 24.51%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Relic Pharma?

In 2021, Relic Pharma had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Relic Pharma?

Unlock and access historical data on people associated with Relic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Relic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relic Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Relic Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Relic Pharma Limited last Annual general meeting of members was held on 19 Aug 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Relic Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Hemant Kantilal Choksey was appointed as a Director was appointed as a Director on 19 Apr 2014 & has been associated with this company since 12 years 1 month . was completed.

  • Director Appointment

    The activity Baijoo Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 31 years 19 days . was completed.

  • Director Appointment

    The activity Uday Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 31 years 19 days . was completed.

  • Company Incorporation

    The activity Relic Pharma Limited was registered on 04 May 1995 with Roc Mumbai & aged 31 years 19 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Relic Pharma Limited?

The CIN of Relic Pharma Limited is U67120MH1995PLC088000.

Where is Relic Pharma Limited headquartered?

Relic Pharma Limited is headquartered at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, 400002.

When was Relic Pharma Limited incorporated?

Relic Pharma Limited was incorporated on 04 May 1995.

Who are the current directors of Relic Pharma Limited?

The current directors of Relic Pharma Limited are

What is the primary industry of Relic Pharma Limited?

The primary industry of Relic Pharma Limited is Financial And Insurance Service.

Is Relic Pharma Limited a listed company?

Relic Pharma Limited is unlisted.

What is the capital structure of Relic Pharma Limited?

The authorized capital of Relic Pharma Limited is ₹3.25 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Relic Pharma Limited?

The compliance status of Relic Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available